EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Imaging Flow Cytometry Detection of Cytogenetic Abnormalities in Circulating CD34 + Cells Predicts Leukemic Transformation in Myelofibrosis

Ruby M Hamilton iD, Ryan J Collinson iD, Henry Y Hui iD, Zi Yun Ng, Hun S Chuah iD, Malcolm Webb, Belinda B Guo iD, Wendy N Erber iD, Kathy A Fuller iD

Cytometry Part A · 2026

DOI: 10.1002/cytoa.70012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cytometry Part A, 2026. Verfasst von Ruby M Hamilton und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Sciences, University of Western Australia, Crawley, WA, Australia. Hauptthemen laut MEDLINE: Primary Myelofibrosis, Flow Cytometry, Antigens, CD34, Chromosome Aberrations. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Royal Perth Hospital Medical Research Foundation, Perpetual Philanthropic, Snowdome Foundation and Maddie Riewoldt's Vision.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myelofibrosis is a myeloproliferative neoplasm with potential to transform to acute myeloid leukemia. This evolution is unpredictable and current assays lack the sensitivity and applicability needed to predict this transformation. While population‐level data utilizing comprehensive genomic profiling can identify subgroups at higher risk of progression, they do not provide individualized information on the likelihood or timing of leukemia. Cytogenetic alterations are typically present in secondary leukemia. We aimed to determine whether these changes could be detected at an early stage. To achieve this we established and tested a single‐cell imaging flow cytometric method for chromosomal aberrations using fluorescence in situ hybridization (FISH) probes to analyze circulating CD34/CD45‐positive cells. Peripheral blood samples from 14 patients, collected at up to eight timepoints over a 34‐month period, were analyzed for defects involving chromosomes 1, 5, and 17. Following cell immunophenotyping and FISH probe hybridization, a mean of 174,216 mononuclear cells was assessed per sample. Chromosomal abnormalities including gain(1q), del(5q), idic (5), monosomy 17, and/or del(17p) were identified in eight patients, at frequencies down to 0.2% of mononuclear cells. Serial analyses revealed emergence of new chromosomal lesions, clonal evolution, dominance, and multi‐hit abnormalities. In three patients, acquired chromosome 17 abnormalities preceded progression to secondary leukemia by up to 7 months. This pilot study demonstrates that imaging flow cytometry‐based FISH of circulating CD34/CD45‐positive cells enables real‐time, blood‐based surveillance for cytogenetic evolution in myelofibrosis. The ability to dynamically track clone size and hierarchy highlights its potential as an early predictor of leukemic transformation in myelofibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Primary MyelofibrosisFlow CytometryAntigens, CD34Chromosome AberrationsLeukemia, Myeloid, AcuteCell Transformation, NeoplasticHumansIn Situ Hybridization, FluorescenceFemaleMaleAgedMiddle AgedImmunophenotypingAged, 80 and overAdult

Stichwörter der Autor:innen

CD34‐positive cellsfluorescence in situ hybridizationimaging flow cytometrymyelofibrosissecondary AML

Substanzen

Antigens, CD34

Autor:innen und Institutionen

  • School of Biomedical Sciences, University of Western Australia, Crawley, WA, Australia.
  • Department of Haematology, Royal Perth Hospital, Perth, WA, Australia.
  • PathWest Laboratory Medicine, Nedlands, WA, Australia.
  • Hollywood Hospital, Hollywood, Nedlands, WA, Australia.

ORCID-Profile: Ruby M Hamilton, Ryan J Collinson, Henry Y Hui, Hun S Chuah, Belinda B Guo, Wendy N Erber, Kathy A Fuller

Förderung

  • Royal Perth Hospital Medical Research Foundation
  • Perpetual Philanthropic
  • Snowdome Foundation and Maddie Riewoldt's Vision

Zitieren

APA

Hamilton, R. M., Collinson, R. J., Hui, H. Y., Ng, Z. Y., Chuah, H. S., Webb, M., Guo, B. B., Erber, W. N., & Fuller, K. A. (2026). Imaging Flow Cytometry Detection of Cytogenetic Abnormalities in Circulating CD34 + Cells Predicts Leukemic Transformation in Myelofibrosis. Cytometry Part A. https://doi.org/10.1002/cytoa.70012

Vancouver

Hamilton RM, Collinson RJ, Hui HY, Ng ZY, Chuah HS, Webb M, et al. Imaging Flow Cytometry Detection of Cytogenetic Abnormalities in Circulating CD34 + Cells Predicts Leukemic Transformation in Myelofibrosis. Cytometry Part A. 2026. doi:10.1002/cytoa.70012

BibTeX
@article{Hamilton2026,
  author = {Hamilton, Ruby M and Collinson, Ryan J and Hui, Henry Y and Ng, Zi Yun and Chuah, Hun S and Webb, Malcolm and Guo, Belinda B and Erber, Wendy N and Fuller, Kathy A},
  title = {Imaging Flow Cytometry Detection of Cytogenetic Abnormalities in Circulating CD34 + Cells Predicts Leukemic Transformation in Myelofibrosis},
  journal = {Cytometry Part A},
  year = {2026},
  doi = {10.1002/cytoa.70012}
}
Kostenlos starten →